Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function

Lignende værker

• Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease
  af: Lo, Arthur, et al.
  Udgivet: (2020)
• Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study
  af: Borin, Marie T., et al.
  Udgivet: (2019)
• Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function
  af: Berg, Jolene K., et al.
  Udgivet: (2018)
• Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment
  af: Jamieson, Brian D., et al.
  Udgivet: (2015)
• Pharmacokinetics and safety of olodaterol administered with the Respimat Soft Mist inhaler in subjects with impaired hepatic or renal function
  af: Kunz C, et al.
  Udgivet: (2016-03-01)